[1]Kitzman DW, Scholz DG, Hagen PT,et al. Age-related changes in normal human hearts during the first 10 decades of life. Part II (Maturity):A quantitative anatomic study of 765 specimens from subjects 20 to 99 years old[J].Mayo Clin Proc, 1988 ,63(2):137-146.
[2]Paulsen S, Vetner M, Hagerup LM. Relationship between heart weight and the cross sectional area of the coronary ostia[J]. Acta Pathol Microbiol Scand A, 1975 ,83(5):429-432.
[3]Davies PF. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology[J]. Nat Clin Pract Cardiovasc Med, 2009, 6(1):16-26.
[4]Holder SM, Brislane á, Dawson EA, et al. Relationship Between Endothelial Function and the Eliciting Shear Stress Stimulus in Women: Changes Across the Lifespan Differ to Men[J]. J Am Heart Assoc, 2019, 8(4):e010994.
[5]Sydó N, Abdelmoneim SS, Mulvagh SL, et al.Relationship between exercise heart rate and age in men vs women[J]. Mayo Clin Proc, 2014, 89(12):1664-1672.
[6]Spaan J, Kolyva C, van den Wijngaard J, et al. Coronary structureand perfusion in health and disease[J]. Philos Trans A Math Phys Eng Sci, 2008, 366(1878):3137-3153.
[7]Franklin BA, Chaddha A. Resting Heart Rate and Blood Pressure asIndices of Cardiovascular and Mortality Risk: IS LOWER INVARIABLY BETTER?[J]. J Cardiopulm Rehabil Prev, 2018, 38(6):353-357.
[8]Coutinho T, Mielniczuk LM, Srivaratharajah K,et al. Coronary artery microvascular dysfunction: Role of sex and arterial load[J]. Int J Cardiol, 2018, 270:42-47.
[9]Huxley VH, Kemp SS. Sex-Specific Characteristics of the Microcirculation[J]. Adv Exp Med Biol, 2018, 1065:307-328.
[10]Leblanc AJ, Chen B, Dougherty PJ, et al. Divergent effects of aging and sex on vasoconstriction to endothelin in coronary arterioles[J]. Microcirculation, 2013, 20(5):365-376.
[11]Huxley VH, Kemp SS. Sex-Specific Characteristics of the Microcirculation[J]. AdvExp Med Biol, 2018, 1065:307-328.
[12]Sara JD, Widmer RJ, Matsuzawa Y, et al. Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease[J]. JACC Cardiovasc Interv, 2015, 8(11):1445-1453.
[13]Zaman MJ, Junghans C, Sekhri N, et al.Presentation of stable angina pectoris among women and South Asian people[J]. CMAJ, 2008, 179(7):659-667.
[14]Mehta PK, Bess C, Elias-Smale S, et al. Gender in cardiovascular medicine: chest pain andcoronary artery disease[J]. Eur Heart J, 2019, 40(47):3819-3826.
[15]Pepine CJ, Abrams J, Marks RG, et al.Characteristics of a contemporary population with angina pectoris. TIDES Investigators[J]. Am J Cardiol, 1994, 74(3):226-231.
[16]Sara JD, Taher R, Kolluri N, et al. Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease[J].Cardiovasc Diabetol, 2019, 18(1):22.
[17]Kul ?, Güven? TS, Baycan ?F, et al. Combined past preeclampsia and gestational diabetes is associated with a very high frequency of coronary microvascular dysfunction[J]. Microvasc Res, 2021, 134:104104.?
[18]Haas AV, Rosner BA, Kwong RY, et al. Sex Differences in Coronary Microvascular Function in IndividualsWith Type 2 Diabetes[J]. Diabetes, 2019, 68(3):631-636.
[19]Antonios TF. Microvascular rarefaction in hypertension--reversal or over-correction by treatment?[J] Am J Hypertens, 2006, 19(5):484-485.
[20]Pries AR, Badimon L, Bugiardini R, et al. Coronary vascular regulation,remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation[J].Eur Heart J, 2015, 36(45):3134-3146.
[21]M?nnist? T, Mendola P, V??r?sm?ki M, et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk[J]. Circulation, 2013, 127(6):681-690.
[22]Park K, Quesada O, Cook-Wiens G, et al. Adverse Pregnancy Outcomes Are Associated with Reduced Coronary Flow Reserve in Women With Signs and Symptoms of Ischemia Without Obstructive Coronary Artery Disease: A Report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study[J]. J Womens Health (Larchmt), 2020, 29(4):487-492.
[23]Dorobantu M, Onciul S, Tautu OF, et al. Hypertension and IschemicHeart Disease in Women[J]. Curr Pharm Des, 2016, 22(25):3885-3892.
[24]Orio F Jr, Palomba S, Cascella T, et al. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome[J]. J Clin Endocrinol Metab, 2004, 89(9):4588-4593.
[25]Talbott EO, Zborowski J, Rager J, et al. Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?[J] Vasc Health Risk Manag, 2008, 4(2):453-462.
[26]Bozbas H, Pirat B, Yildirir A,et al. Coronary microvascular function in patients with isolated systolic and combined systolic/diastolic hypertension[J]. J Clin Hypertens (Greenwich), 2012, 14(12):871-876.
[27]Mygind ND, Michelsen MM, Pena A, et al.Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study[J]. J Am Heart Assoc, 2016, 5(3):e003064.
[28]Mayala HA, Yan W, Jing H, et al. Clinical characteristics and biomarkers of coronary microvascular dysfunction and obstructive coronary artery disease[J]. J Int Med Res, 2019,47(12):6149-6159.
[29]Chaudhary R, Sukhi A, Chaudhary R, et al. Gender differences in thrombogenicity among patients with angina and non-obstructive coronary artery disease[J]. J Thromb Thrombolysis, 2019, 48(3):373-381.
[30]Wong ND, Pio J, Valencia R, et al. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease riskestimation in the National Health and Nutrition Examination Survey (NHANES) III[J]. Prev Cardiol, 2001, 4(3):109-114.
[31]Schroder J, Mygind ND, Frestad D, et al. Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction[J]. Int J CardiolHeart Vasc, 2019, 24:100370.
[32]Prasad M, Matteson EL, Herrmann J, et al. Uric Acid Is Associated With Inflammation, Coronary Microvascular Dysfunction, and Adverse Outcomes in Postmenopausal Women[J]. Hypertension, 2017, 69(2):236-242.
[33]Tona F, Serra R, Di Ascenzo L, et al. Systemic inflammation is related to coronary microvascular dysfunction in obese patients withoutobstructive coronary disease[J]. Nutr Metab Cardiovasc Dis, 2014, 24(4):447-453.
[34]Bagi Z, Broskova Z, Feher A. Obesity and coronary microvascular disease -implications for adipose tissue-mediated remote inflammatory response[J]. Curr Vasc Pharmacol, 2014, 12(3):453-461.
[35]Wassmann S, Stumpf M, Strehlow K, et al.Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor[J]. Circ Res, 2004, 94(4):534-541.
[36]Zhang C, Hein TW, Wang W,et al. Activation of JNK and xanthine oxidase by TNF-alpha impairs nitric oxide-mediated dilation of coronary arterioles[J]. J Mol Cell Cardiol, 2006, 40(2):247-257.
[37]Kennedy A, Gettys TW, Watson P,et al. The metabolic significance of leptin in humans: gender-based differences inrelationship to adiposity, insulin sensitivity, and energy expenditure[J]. J Clin Endocrinol Metab, 1997, 82(4):1293-1300.
[38]Vaccarino V, Khan D, Votaw J, et al. Inflammation is related to coronary flow reserve detected by positron emission tomography in asymptomatic male twins[J]. J Am Coll Cardiol, 2011, 57(11):1271-1279.
[39]Tong DC, Whitbourn R, MacIsaac A, et al.High-Sensitivity C-Reactive Protein Is a Predictor of Coronary Microvascular Dysfunction in Patients with Ischemic Heart Disease[J]. Front Cardiovasc Med, 2018, 4:81.
[40]Recio-Mayoral A, Mason JC, Kaski JC, et al. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease[J]. Eur Heart J, 2009, 30(15):1837-1843.
[41]Zanatta E, Colombo C, D'Amico G, et al.Inflammation and Coronary Microvascular Dysfunction in Autoimmune Rheumatic Diseases[J]. Int J Mol Sci, 2019, 20(22):5563.
[42]Groepenhoff F, Bots SH, Kessler EL, et al. Sex-Specific Aspects in the Pathophysiology and Imaging of Coronary Macro- and Microvascular Disease[J]. J Cardiovasc Transl Res, 2020, 13(1):39-46.
[43]Dworatzek E, Mahmoodzadeh S, Schriever C, et al. Sex-specific regulation of collagen I and III expression by 17β-Estradiol in cardiac fibroblasts: role of estrogen receptors[J]. Cardiovasc Res, 2019, 115(2):315-327.
[44]Moreau KL, Hildreth KL. Vascular Aging across the Menopause Transition in Healthy Women[J]. Adv Vasc Med, 2014, 2014:204390.
[45]Beale AL, Meyer P, Marwick TH, et al. Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction[J]. Circulation, 2018, 138(2):198-205.
[46]Arenas IA, Armstrong SJ, Xu Y, et al. Chronic tumor necrosis factor-alpha inhibition enhances NO modulation of vascular function in estrogen-deficient rats[J]. Hypertension, 2005, 46(1):76-81.
[47]Sickinghe AA, Korporaal SJA, den Ruijter HM, et al. Estrogen Contributions to Microvascular Dysfunction Evolving to Heart Failure With Preserved Ejection Fraction[J]. Front Endocrinol (Lausanne), 2019, 10:442.
[48]Vaccarino V, Bremner JD. Behavioral, emotional and neurobiological determinants of coronary heart disease risk in women[J]. Neurosci Biobehav Rev, 2017, 74(Pt B):297-309.
[49]Sullivan S, Hammadah M, Al Mheid I, et al. Sex Differences in Hemodynamic and Microvascular Mechanisms of Myocardial Ischemia Induced by Mental Stress[J]. Arterioscler Thromb Vasc Biol, 2018, 38(2):473-480.
[50]Vaccarino V, Votaw J, Faber T, et al. Major depression and coronary flow reserve detected by positron emission tomography[J]. Arch InternMed, 2009, 169(18):1668-1676.
[51]Martínez de Toda I, Miguélez L, Siboni L, et al.High perceived stress in women is linked to oxidation, inflammation and immunosenescence[J]. Biogerontology, 2019, 20(6):823-835.